4Heterogeneity in the regenerative abilities of central nervous system axons within species: why do some neurons regenerate better than others?REVIEW996-1005
5Locus coeruleus-norepinephrine: basic functions and insights into Parkinson’s diseaseREVIEW1006-1013
6Stroke gets in your eyes: stroke-induced retinal ischemia and the potential of stem cell therapyREVIEW1014-1018
7Using our mini-brains: cerebral organoids as an improved cellular model for human prion diseasePERSPECTIVE1019-1020
9Exosome-mediated crosstalk between microglia and neural stem cells in the repair of brain injuryPERSPECTIVE1023-1024
10The extended renin-angiotensin system: a promising target for traumatic brain injury therapeuticsPERSPECTIVE1025-1026
11A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression:focus on dopaminergic systemPERSPECTIVE1027-1029
12Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic targetPERSPECTIVE1030-1032
14Abscisic acid, a promising therapeutic molecule to prevent Alzheimer’s and neurodegenerative diseasesPERSPECTIVE1035-1036
15Leaky gut, dysbiosis, and enteric glia activation: the trilogy behind the intestinal origin of Parkinson’s diseasePERSPECTIVE1037-1038
16Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitisPERSPECTIVE1039-1040
17Novel small molecule TRVA242 targets neuromuscular junction in amyotrophic lateral sclerosisPERSPECTIVE1041-1042
18Human endogenous retroviruses:ammunition for myeloid cells in neurodegenerative diseases?PERSPECTIVE1043-1044
19Modified constraint-induced movement therapy alters synaptic plasticity of rat contralateral hippocampus following middle cerebral artery occlusionRESEARCH ARTICLE1045-1057
